Medpace Holdings, Inc. (MEDP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q3 '21: 295.6M Q4 '21: 308.6M Q1 '22: 330.9M Q2 '22: 351.2M Q3 '22: 383.7M Q4 '22: 394.1M Q1 '23: 434.1M Q2 '23: 460.9M Q3 '23: 492.5M Q4 '23: 498.4M Q1 '24: 511M Q2 '24: 528.1M Q3 '24: 533.3M Q4 '24: 536.6M Q1 '25: 558.6M Q2 '25: 603.3M Q3 '25: 659.9M Q4 '25: 708.5M Q1 '26: 706.6M Q2 '26: 707.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 60M 120M 180M Q3 '21: 53.7M Q4 '21: 54.9M Q1 '22: 64.2M Q2 '22: 60.2M Q3 '22: 77.8M Q4 '22: 76.4M Q1 '23: 86.2M Q2 '23: 78.4M Q3 '23: 84.9M Q4 '23: 87.3M Q1 '24: 104.1M Q2 '24: 105.2M Q3 '24: 112.3M Q4 '24: 125.4M Q1 '25: 113.5M Q2 '25: 126.3M Q3 '25: 141.8M Q4 '25: 153.3M Q1 '26: 141.5M Q2 '26: 146.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 50M 100M 150M Q3 '21: 48.6M Q4 '21: 50M Q1 '22: 61.3M Q2 '22: 49.4M Q3 '22: 66M Q4 '22: 68.7M Q1 '23: 72.9M Q2 '23: 61.1M Q3 '23: 70.5M Q4 '23: 78.3M Q1 '24: 102.6M Q2 '24: 88.4M Q3 '24: 96.4M Q4 '24: 117M Q1 '25: 114.6M Q2 '25: 90.3M Q3 '25: 111.1M Q4 '25: 135.1M Q1 '26: 123.9M Q2 '26: 121.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 90M 180M 270M Q3 '21: 72.4M Q4 '21: 70.9M Q1 '22: 46.3M Q2 '22: 96.6M Q3 '22: 108.5M Q4 '22: 136.7M Q1 '23: 80.1M Q2 '23: 82.5M Q3 '23: 114.4M Q4 '23: 156.4M Q1 '24: 152.7M Q2 '24: 116.4M Q3 '24: 149.1M Q4 '24: 190.7M Q1 '25: 125.8M Q2 '25: 148.5M Q3 '25: 246.2M Q4 '25: 192.7M Q1 '26: 151.8M Q2 '26: 162M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

0 90M 180M 270M Q3 '21: 65.7M Q4 '21: 61.8M Q1 '22: 37M Q2 '22: 85.4M Q3 '22: 101.3M Q4 '22: 127.4M Q1 '23: 70.6M Q2 '23: 74.1M Q3 '23: 105.7M Q4 '23: 146.4M Q1 '24: 147.2M Q2 '24: 103.5M Q3 '24: 138.5M Q4 '24: 183M Q1 '25: 115.8M Q2 '25: 142.4M Q3 '25: 235.5M Q4 '25: 188.1M Q1 '26: 145M Q2 '26: 138.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '20: 38M Q2 '20: 37.3M Q3 '20: 37.8M Q1 '21: 37.7M Q2 '21: 37.7M Q3 '21: 37.5M Q1 '22: 36.4M Q2 '22: 33.7M Q3 '22: 32.3M Q1 '23: 32.2M Q2 '23: 31.6M Q3 '23: 31.8M Q1 '24: 32M Q2 '24: 32.1M Q3 '24: 32.1M Q1 '25: 31.2M Q2 '25: 29.1M Q3 '25: 28.8M Q1 '26: 29M Q2 '26: 28.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 6.00 12.00 18.00 Q3 '21: 4.83 Q4 '21: 4.81 Q1 '22: 5.36 Q2 '22: 5.76 Q3 '22: 6.52 Q4 '22: 7.30 Q1 '23: 7.88 Q2 '23: 8.35 Q3 '23: 8.52 Q4 '23: 8.88 Q1 '24: 9.81 Q2 '24: 10.63 Q3 '24: 11.42 Q4 '24: 12.63 Q1 '25: 13.10 Q2 '25: 13.45 Q3 '25: 14.30 Q4 '25: 15.27 Q1 '26: 15.88 Q2 '26: 17.03 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.